Topical tacrolimus for superficial tufted angioma: A randomized clinical trial

Name: Topical tacrolimus for superficial tufted angioma: A randomized clinical trial
Creator: Jiangyuan Zhou
Published: 2025-11-03T11:06:14.432Z
Keywords: Hemangioma

Zhou, Jiangyuan; Gong, Xue; Yang, Min; Zhang, Zixin; Qiu, Tong; Lan, Yuru; Zhang, Xuepeng; Yang, Congxia; Zhou, Zilong; Zhang, Yujia; Zhang, Kaizhi; He, Chunshui; Peng, Qiang; Hou, Fang; Hu, Fan; Xia, Chunchao; Shan, Wei; Bao, Pingqian; Chen, Siyuan; Ji, Yi

doi:10.17632/ddn3vfwr8z.1

Topical tacrolimus for superficial tufted angioma: A randomized clinical trial

Published: 3 November 2025| Version 1 | DOI: 10.17632/ddn3vfwr8z.1

Contributors:

Jiangyuan Zhou, Xue Gong, Min Yang, Zixin Zhang, Tong Qiu, Yuru Lan, Xuepeng Zhang, Congxia Yang, Zilong Zhou, Yujia Zhang, Kaizhi Zhang, Chunshui He, Qiang Peng, Fang Hou, Fan Hu, Chunchao Xia, Wei Shan, Pingqian Bao, Siyuan Chen, Yi Ji

Description

Tufted angioma (TA) is a rare vascular tumor that occurs predominantly in infancy or early childhood. However, no standard therapeutic management currently exists. Therefore, this study aimed to evaluate the efficacy and safety of topical tacrolimus at different concentrations for treating TA.

Topical tacrolimus for superficial tufted angioma: A randomized clinical trial

Description

Files

Categories

Licence